Next, we treated RT4 and T24 cells with siRNA-AURKA (Si-AURKA), miR-490-3p inhibitor (inhibitor), and negative control (NC) to study the role of AURKA in bladder cancer. The gene discussed is AURKA; the disease is urinary bladder carcinoma.